| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Soleno Therapeutics, Inc. (SLNO) has 9 insiders with recent SEC Form 4 filings, including 21 buys and 0 sells. SLNO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 569.5K | $30.19M | - | |
| CFO | 103.2K | $5.47M | - | |
| Other | 72.3K | $3.83M | - | |
| Other | 67.2K | $3.56M | - | |
| Other | 64.3K | $3.41M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 15, 2018 | Feinberg Larry N | 10% Owner | Buy | 50,000 | $1.80 | $89,780.46 | +1.1% | |
| Dec 15, 2017 | Engleman Edgar60 | Director, 10% Owner | Buy | 1,085,480 | $1.84 | $1,999,996.90 | +15.6% | |
| Dec 15, 2017 | Vivo Ventures V, LLC | 10% Owner | Buy | 1,085,480 | $1.84 | $1,999,996.90 | +38.1% | |
| Mar 7, 2017 | Vivo Ventures V, LLC | 10% Owner | Buy | 1,488,213 | $0.91 | $1,354,042.56 | +5.8% | |
| Mar 7, 2017 | Engleman Edgar60 | Director, 10% Owner | Buy | 1,488,213 | $0.91 | $1,354,042.56 | +2.7% | |
| Mar 7, 2017 | Tp Management VII LLC | 10% Owner | Buy | 77,752 | $0.00 | - | +1.1% | |
| Aug 19, 2016 | Anish Bhatnagar | See Remarks | Buy | 10,000 | $0.96 | $9,600.00 | +13.6% | |
| Aug 18, 2016 | O'Toole David D47 | See Remarks | Buy | 2,000 | $1.01 | $2,020.00 | +4.7% | |
| Aug 18, 2016 | Mario Ernest | Director, 10% Owner | Buy | 25,000 | $0.99 | $24,750.00 | +1.4% | |
| Aug 17, 2016 | O'Toole David D47 | See Remarks | Buy | 10,000 | $0.92 | $9,238.00 | +30.5% |